V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005835 | 320004188 | 1.69 | 61.4 | Adjuvant (A) | 2017-07-24 | 2017-07-24 | Carboplatin + Cetux + FU (>Cycle 2) | Y | null | 320012248 | OXALIPLATIN + MDG |
| 320005836 | 320004188 | null | 59.2 | Palliative (P) | 2018-11-08 | 2018-11-17 | Gemcitabine weekly | N | null | 320012248 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320005837 | 320004189 | null | null | Neo-adjuvant (N) | 2015-09-08 | 2015-09-10 | VAC | 2 | N | 320012878 | PEMBROLIZUMAB |
| 320005838 | 320004190 | 1.46 | 68.8 | Palliative (P) | 2014-02-13 | 2014-02-14 | CARBO + FLUOROURACIL | 02 | N | 320012878 | DOCETAXEL + GEMCITABINE |
| 320005839 | 320004190 | 1.79 | 57.6 | Neo-adjuvant (N) | null | 2015-06-26 | Carboplatin + Etoposide IV 3 day | N | N | 320012878 | IRINOTECAN + TEMOZOLOMIDE |
| 320005840 | 320004191 | null | 21 | Palliative (P) | 2014-09-13 | 2014-09-22 | Irinotecan + Modified De Gramont | N | N | 320012960 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005841 | 320004192 | 1.84 | 67 | Palliative (P) | 2013-09-07 | 2013-09-10 | Cetuximab + Radiotherapy Maint | N | N | 320012978 | DOCETAXEL |
| 320005842 | 320004193 | 1.74 | null | Palliative (P) | 2017-06-08 | 2018-11-12 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 320013012 | DOCETAXEL |
| 320005843 | 320004193 | 1.79 | 80.8 | Curative (C) | 2017-01-21 | 2017-01-21 | Carboplatin + Etoposide IV 3 day | 2 | N | 320013012 | TEMOZOLOMIDE |
| 320005844 | 320004194 | 1.62 | null | Adjuvant (A) | 2017-08-09 | 2017-08-12 | CISPLATIN + GEMCITABINE | N | Y | 320013335 | CISPLATIN + ETOPOSIDE |
| 320005845 | 320004195 | 1.78 | null | Adjuvant (A) | 2017-01-29 | 2017-02-28 | Irinotecan + Modified De Gramont | N | N | 320013419 | NIVOLUMAB |
| 320005846 | 320004196 | 1.76 | 94.6 | Palliative (P) | 2015-07-26 | 2015-08-04 | PEMBROLIZUMAB | 02 | Y | 320013442 | CETUXIMAB + CISPLATIN + FU |
| 320005847 | 320004197 | 1.54 | 64.6 | Palliative (P) | 2014-11-07 | 2014-11-22 | Topotecan (intravenous) | N | N | 320013788 | CARBOPLATIN + PEMETREXED |
| 320005848 | 320005925 | 1.76 | 58.7 | Palliative (P) | 2018-06-24 | 2018-08-05 | PEMBROLIZUMAB | 02 | N | 320013895 | CAPECITABINE + OXALIPLATIN |
| 320005849 | 320005925 | 1.6 | 72.4 | Curative (C) | 2018-07-11 | 2018-08-08 | FLUOROURACIL + OXALIPLATIN | N | N | 320013895 | DOCETAXEL + GEMCITABINE |
| 320005850 | 320004200 | 1.66 | 61 | null | 2018-06-19 | 2018-06-19 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | N | 320014425 | IVA |
| 320005851 | 320005926 | 1.75 | null | Not known (9) | 2017-05-05 | 2017-06-17 | Temozolomide 200mg/m2 | N | N | 320014489 | RMS 2005 TRIAL |
| 320005852 | 320005926 | 1.91 | 99 | Palliative (P) | 2013-11-07 | 2013-11-10 | Cyclophosphamide PO +Vinorelbine IV | N | N | 320014489 | CETUXIMAB + CISPLATIN + FU |
| 320005853 | 320005926 | 1.6 | 62.8 | Palliative (P) | 2019-06-02 | 2019-06-20 | ICON8 TRIAL | N | null | 320014489 | CARBOPLATIN + RT |
| 320005854 | 320004201 | 1.54 | 82.8 | Palliative (P) | 2017-02-10 | 2017-02-18 | ECX | 02 | N | 320015394 | PEMBROLIZUMAB |
| 320005855 | 320004202 | 1.68 | null | Curative (C) | 2018-02-15 | 2018-04-13 | Irinotecan + Temozolomide | N | N | 320015394 | CAPECITABINE + OXALIPLATIN |
| 320005856 | 320004202 | 1.66 | 59.5 | Curative (C) | 2017-12-29 | 2018-01-08 | Etoposide oral | N | N | 320015394 | IMATINIB |
| 320005857 | 320004202 | 1.65 | 59.9 | Palliative (P) | null | 2017-03-24 | ICON8B TRIAL | N | N | 320015394 | DOCETAXEL |
| 320005858 | 320004204 | 1.81 | 87.5 | Palliative (P) | null | 2016-05-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320015999 | TCF |
| 320005859 | 320004205 | 1.55 | 67 | Palliative (P) | 2017-02-08 | 2017-02-12 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 320016064 | IPILIMUMAB |
| 320005860 | 320005929 | 1.6 | 82.2 | Palliative (P) | 2016-08-19 | 2016-08-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320016335 | CARBOPLATIN + CETUXIMAB + FU |
| 320005861 | 320006750 | 1.6 | 74 | Palliative (P) | 2017-05-19 | 2017-06-02 | LANREOTIDE | N | N | 320016488 | OXALIPLATIN + MDG |
| 320005862 | 320007138 | 1.59 | 66.9 | Adjuvant (A) | 2017-08-06 | 2017-08-25 | IVA | 2 | N | 320016619 | RITUXIMAB |
| 320005863 | 320004208 | 1.76 | 105.4 | Palliative (P) | 2018-07-29 | 2018-07-29 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 320016972 | CISPLATIN + GEMCITABINE |
| 320005864 | 320004209 | 1.68 | 75.4 | Palliative (P) | 2016-05-07 | 2016-05-12 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 320017019 | NIVOLUMAB |
| 320005865 | 320004209 | 1.7 | null | Not known (9) | 2014-04-10 | 2014-04-10 | TEMOZOLOMIDE | N | null | 320017019 | CETUXIMAB + RT |
| 320005866 | 320006751 | 1.78 | 81 | Palliative (P) | 2013-11-07 | 2013-11-25 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | 320017263 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 320005867 | 320006751 | 1.83 | null | Curative (C) | null | 2014-05-10 | PEMBROLIZUMAB | N | null | 320017263 | IPILIMUMAB |
| 320005868 | 320004210 | null | 57.2 | Palliative (P) | 2017-09-30 | 2017-10-09 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | N | 320017340 | NIRAPARIB |
| 320005869 | 320005931 | null | 0 | Palliative (P) | 2017-05-30 | 2017-06-08 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320017413 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320005870 | 320005932 | 1.57 | 47.5 | Adjuvant (A) | 2015-06-23 | 2015-07-04 | Carboplatin + Pemetrexed | Y | 2 | 320017509 | DOXORUBICIN |
| 320005871 | 320005932 | 1.72 | 57 | Palliative (P) | 2015-01-08 | 2015-02-12 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 320017509 | CETUXIMAB + CISPLATIN + FU |
| 320005872 | 320004213 | null | 73.7 | Palliative (P) | 2018-11-08 | 2018-11-14 | POMALIDOMIDE | 2 | N | 320017830 | VINCRISTINE |
| 320005873 | 320005933 | 1.73 | null | Palliative (P) | null | 2015-12-30 | Mitomycin Intravesical | null | null | 320017929 | ENZALUTAMIDE |
| 320005874 | 320004214 | 1.8 | 80 | Palliative (P) | 2016-09-29 | 2016-10-21 | PEMBROLIZUMAB | N | N | 320017986 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320005875 | 320005934 | 1.78 | 69.1 | Palliative (P) | 2016-07-11 | 2016-07-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 320018048 | CISPLATIN + GEMCITABINE |
| 320005876 | 320004216 | 1.8 | 79.3 | null | 2018-03-26 | 2019-08-12 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | N | 320018067 | CISPLATIN + FLUOROURACIL + RT |
| 320005877 | 320005935 | 1.78 | 80.5 | Curative (C) | 2016-12-17 | 2016-12-27 | Mitomycin Intravesical | N | N | 320018267 | CARBOPLATIN + RT |
| 320005878 | 320004217 | 1.86 | 0 | Palliative (P) | 2017-12-27 | 2018-01-21 | CARBOPLATIN + CETUXIMAB + FU | 2 | N | 320018367 | CISPLATIN + ETOPOSIDE |
| 320005879 | 320004219 | 1.66 | 93.6 | Neo-adjuvant (N) | 2017-06-22 | 2017-09-05 | Doxorubicin chemoembolisation | N | N | 320018460 | CISPLATIN + ETOPOSIDE |
| 320005880 | 320004220 | 1.66 | 93 | Palliative (P) | 2016-09-09 | 2016-09-29 | NIVOLUMAB | N | N | 320018568 | CARBOPLATIN + CETUXIMAB + FU |
| 320005881 | 320004221 | -1 | null | Palliative (P) | 2018-01-29 | 2018-03-02 | Carboplatin + Etoposide IV 3 day | N | N | 320018708 | PEMBROLIZUMAB |
| 320005882 | 320004222 | null | null | Palliative (P) | 2013-10-01 | 2013-10-26 | Cetuximab+Cisplatin+FU (> Cycle 2) | null | null | 320018738 | IVA |
| 320005883 | 320004223 | 1.72 | 65 | Palliative (P) | 2015-09-07 | 2015-09-08 | BENDAMUSTINE + RITUXIMAB | N | N | 320018779 | MITOMYCIN INTRAVESICULAR |
| 320005884 | 320004224 | 1.67 | 56.6 | Curative (C) | 2013-12-12 | 2014-01-11 | ICON8B TRIAL | N | N | 320018848 | IRINOTECAN + BEVACIZUMAB |